Spojené státy - angličtina - NLM (National Library of Medicine)

armas pharmaceuticals inc. - milrinone lactate (unii: 9k8xr81mo8) (milrinone - unii:ju9yax04c7) - milrinone lactate injection is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. patients receiving milrinone should be observed closely with appropriate electrocardiographic equipment. the facility for immediate treatment of potential cardiac events, which may include life threatening ventricular arrhythmias, must be available. the majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. there is no experience in controlled trials with infusions of milrinone for periods exceeding 48 hours. milrinone lactate injection is contraindicated in patients who are hypersensitive to it.

Spojené státy - angličtina - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - milrinone lactate (unii: 9k8xr81mo8) (milrinone - unii:ju9yax04c7) - 200 ug in 1 ml

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - milrinone, quantity: 10 mg - injection, concentrated - excipient ingredients: glucose; water for injections; sodium hydroxide; lactic acid - milrinone-baxter is indicated for the short term (48 hours) intravenous therapy of severe congestive heart failure patients in intensive care and coronary care units not responding to other therapy (e.g. digoxin, diuretics, vasodilators, including ace inhibitors). the majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. ,milrinone-baxter is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - milrinone, quantity: 10 mg - injection, concentrated - excipient ingredients: water for injections; glucose; lactic acid; sodium hydroxide - milrinone gh concentrated injection is indicated for the short term (48 hours) intravenous therapy of severe congestive heart failure patients in intensive care and coronary care units not responding to other therapy (eg. digoxin, diuretics, vasodilators, including ace inhibitors). the majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. - milrinone gh concentrated injection is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - milrinone lactate 1.43 mg/ml equivalent to milrinone 1 mg/ml - concentrate for injection - 1 mg/ml - active: milrinone lactate 1.43 mg/ml equivalent to milrinone 1 mg/ml excipient: glucose lactic acid sodium hydroxide water for injection - milrinone-baxter is indicated for the short term intravenous therapy of severe congestive heart failure. the majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics.

Malta - angličtina - Medicines Authority

wockhardt uk limited - milrinone - solution for infusion or injection - milrinone 1 mg/ml - cardiac therapy

Malta - angličtina - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - milrinone - solution for infusion or injection - milrinone 1 mg/ml - cardiac therapy

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

max health limited - milrinone 1 mg/ml - concentrate for injection - 1 mg/ml - active: milrinone 1 mg/ml excipient: glucose lactic acid sodium hydroxide water for injection - milrinone is indicated for the short term intravenous therapy of severe congestive heart failure. the majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - milrinone - solution for injection/infusion - 1 milligram(s)/millilitre - phosphodiesterase inhibitors; milrinone

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - milrinone - solution for injection/infusion - 1 milligram(s)/millilitre - phosphodiesterase inhibitors; milrinone